Sol-Gel Signs $27 M Deal for Dermatology Drug Delivery
Tuesday, February 21, 2012
Company has entered into a second development and licensing agreement with a leading U.S. pharmaceutical company.
Malvern Instruments and Postnova Analytics Co-operate
Friday, February 17, 2012
Both companies co-operate to deliver combined solution for characterizing challenging particulate systems.
Critical Pharmaceuticals and The University of Nottingham to Develop Nano-Enabled Nasal Spray for Osteoporosis
Thursday, February 16, 2012
The Technology Strategy Board and the Engineering and Physical Sciences Research Council (EPSRC) provide grant funding to support the £545,000 project.
Spain Nanotechnology in Nano Tech 2012 Exhibition (Tokyo, Japan)
Tuesday, February 14, 2012
Spanish Nanoscience and Nanotechnology (N&N) companies, science and technology research centers and industry associations are present for the fifth time after receiving 2011 ‘Special Award’.
BioSante Pharmaceuticals Reports Positive LibiGel Safety Data Review for Phase III Program
Monday, February 13, 2012
BioSante Pharmaceuticals Reports Positive LibiGel Safety Data Review for Phase III Program.
Nanoink Announces Launch of Contract Services Program for Live Single Cell Assay Work
Monday, February 13, 2012
Service offering expected to advance research programs involved with toxicity assessment, high content screening, and cell-cell communication.
Marina Biotech Announces Closing of $1.5 MM Bridge Loan
Friday, February 10, 2012
The company announced the closing of a bridge loan pursuant to a Note and Warrant Purchase Agreement.
Bruker Hosts 10th Annual International Nanoscience
Thursday, February 09, 2012
Call for papers for "Seeing at the Nanoscale 2012".
Anacor Pharmaceuticals Announces Preliminary Results from Two Safety Studies
Wednesday, February 08, 2012
AN2728 studies provide positive results, ointment well tolerated on large body surfaces and sensitive skin.
|
|
|
| << | 1 2 3 4 5 6 7 | >> | | Showing Results 1 - 10 of 661 |
|
|
